Bavarian Nordic A/S - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BVNRY Over the counter 2834 www.bavarian-nordic.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bavarian Nordic A/S

AHF Urges Vaccine Equity as Mpox Cases Surge in Sierra Leone - Jun 30th, 2025 1:33 pm
Bavarian Nordic begins mpox vaccine trial in pregnant women and infants - Jun 26th, 2025 5:18 am
Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women - Jun 26th, 2025 12:00 am
Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus - Jun 25th, 2025 11:00 pm
Bavarian Nordic nets $160m from priority review voucher sale - Jun 18th, 2025 9:33 am
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million - Jun 18th, 2025 1:04 am
Bavarian Nordic launches chikungunya vaccine trial for paediatric population - Jun 13th, 2025 8:50 am
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children - Jun 12th, 2025 12:00 am
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - May 16th, 2025 6:35 am
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025 - May 13th, 2025 1:00 am
Bavarian Nordic AS (BVNKF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - May 12th, 2025 7:00 am
Undiscovered European Gems Including 3 Promising Small Caps - May 12th, 2025 4:33 am
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - May 9th, 2025 9:30 am
Bavarian Nordic shares rise 7% following strong Q1 for vaccine sales - May 9th, 2025 5:55 am
Bavarian Nordic Announces Interim Results for the First Three Months of 2025 - May 8th, 2025 11:38 pm
UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025 - May 8th, 2025 8:44 am
US government exercises $144m option for smallpox/mpox vaccine contract - May 6th, 2025 6:11 am
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines - May 6th, 2025 12:56 am
MHRA authorises Bavarian Nordic’s chikungunya virus vaccine - May 2nd, 2025 8:54 am
Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United Kingdom - May 2nd, 2025 12:30 am